Increased Hemoglobin A1c Time in Range Reduces Adverse Health Outcomes in Older Adults With Diabetes
- PMID: 34127496
- PMCID: PMC8385473
- DOI: 10.2337/dc21-0292
Increased Hemoglobin A1c Time in Range Reduces Adverse Health Outcomes in Older Adults With Diabetes
Abstract
Objective: Short- and long-term glycemic variability are risk factors for diabetes complications. However, there are no validated A1C target ranges or measures of A1C stability in older adults. We evaluated the association of a patient-specific A1C variability measure, A1C time in range (A1C TIR), on major adverse outcomes.
Research design and methods: We conducted a retrospective observational study using administrative data from the Department of Veterans Affairs and Medicare from 2004 to 2016. Patients were ≥65 years old, had diabetes, and had at least four A1C tests during a 3-year baseline period. A1C TIR was the percentage of days during the baseline in which A1C was in an individualized target range (6.0-7.0% up to 8.0-9.0%) on the basis of clinical characteristics and predicted life expectancy. Increasing A1C TIR was divided into categories of 20% increments and linked to mortality and cardiovascular disease (CVD) (i.e., myocardial infarction, stroke).
Results: The study included 402,043 veterans (mean [SD] age 76.9 [5.7] years, 98.8% male). During an average of 5.5 years of follow-up, A1C TIR had a graded relationship with mortality and CVD. Cox proportional hazards models showed that lower A1C TIR was associated with increased mortality (A1C TIR 0 to <20%: hazard ratio [HR] 1.22 [95% CI 1.20-1.25]) and CVD (A1C TIR 0 to <20%: HR 1.14 [95% CI 1.11-1.19]) compared with A1C TIR 80-100%. Competing risk models and shorter follow-up (e.g., 24 months) showed similar results.
Conclusions: In older adults with diabetes, maintaining A1C levels within individualized target ranges is associated with lower risk of mortality and CVD.
© 2021 by the American Diabetes Association.
Similar articles
-
Association of hemoglobin A1c stability with mortality and diabetes complications in older adults with diabetes.BMJ Open Diabetes Res Care. 2023 Apr;11(2):e003211. doi: 10.1136/bmjdrc-2022-003211. BMJ Open Diabetes Res Care. 2023. PMID: 37024152 Free PMC article.
-
Association of hemoglobin A1c time in range with risk for diabetes complications.BMJ Open Diabetes Res Care. 2022 Jul;10(4):e002738. doi: 10.1136/bmjdrc-2021-002738. BMJ Open Diabetes Res Care. 2022. PMID: 35820708 Free PMC article.
-
Association between hemoglobin A1c variability and hypoglycemia-related hospitalizations in veterans with diabetes mellitus.BMJ Open Diabetes Res Care. 2021 Jan;9(1):e001797. doi: 10.1136/bmjdrc-2020-001797. BMJ Open Diabetes Res Care. 2021. PMID: 33431600 Free PMC article.
-
Kidney Disease in Diabetes.In: Cowie CC, Casagrande SS, Menke A, Cissell MA, Eberhardt MS, Meigs JB, Gregg EW, Knowler WC, Barrett-Connor E, Becker DJ, Brancati FL, Boyko EJ, Herman WH, Howard BV, Narayan KMV, Rewers M, Fradkin JE, editors. Diabetes in America. 3rd edition. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases (US); 2018 Aug. CHAPTER 22. In: Cowie CC, Casagrande SS, Menke A, Cissell MA, Eberhardt MS, Meigs JB, Gregg EW, Knowler WC, Barrett-Connor E, Becker DJ, Brancati FL, Boyko EJ, Herman WH, Howard BV, Narayan KMV, Rewers M, Fradkin JE, editors. Diabetes in America. 3rd edition. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases (US); 2018 Aug. CHAPTER 22. PMID: 33651560 Free Books & Documents. Review.
-
Complications of Diabetes and Metrics of Glycemic Management Derived From Continuous Glucose Monitoring.J Clin Endocrinol Metab. 2022 May 17;107(6):e2221-e2236. doi: 10.1210/clinem/dgac034. J Clin Endocrinol Metab. 2022. PMID: 35094087 Free PMC article. Review.
Cited by
-
Clinical and Financial Outcomes of a Pilot Pharmacist-Led Continuous Glucose Monitoring Clinic.Innov Pharm. 2024 Mar 18;15(1):10.24926/iip.v15i1.6081. doi: 10.24926/iip.v15i1.6081. eCollection 2024. Innov Pharm. 2024. PMID: 38779111 Free PMC article.
-
Diabetes Mellitus in the Elderly Adults in Korea: Based on Data from the Korea National Health and Nutrition Examination Survey 2019 to 2020.Diabetes Metab J. 2023 Sep;47(5):643-652. doi: 10.4093/dmj.2023.0041. Epub 2023 Aug 7. Diabetes Metab J. 2023. PMID: 37549924 Free PMC article.
-
Glucagon-Like Peptide 1 Receptor Agonists Have the Potential to Revolutionize the Attainment of Target A1C Levels in Type 2 Diabetes-So Why Is Their Uptake So Low?Clin Diabetes. 2023 Spring;41(2):226-238. doi: 10.2337/cd22-0027. Epub 2023 Nov 3. Clin Diabetes. 2023. PMID: 37092151 Free PMC article.
-
Association of hemoglobin A1c stability with mortality and diabetes complications in older adults with diabetes.BMJ Open Diabetes Res Care. 2023 Apr;11(2):e003211. doi: 10.1136/bmjdrc-2022-003211. BMJ Open Diabetes Res Care. 2023. PMID: 37024152 Free PMC article.
-
Association of hemoglobin A1c time in range with risk for diabetes complications.BMJ Open Diabetes Res Care. 2022 Jul;10(4):e002738. doi: 10.1136/bmjdrc-2021-002738. BMJ Open Diabetes Res Care. 2022. PMID: 35820708 Free PMC article.
References
-
- American Diabetes Association . 6. Glycemic targets. Diabetes Care 2017;40:S48–S56 - PubMed
-
- U.S. Department of Veterans Affairs . VA/DOD Clinical Practice Guidelines: Management of Diabetes Mellitus in Primary Care. Accessed 17 April 2020. Available from https://www.healthquality.va.gov/guidelines/CD/diabetes/
-
- Qaseem A, Wilt TJ, Kansagara D, Horwitch C, Barry MJ; Clinical Guidelines Committee of the American College of Physicians . Hemoglobin A1c targets for glycemic control with pharmacologic therapy for nonpregnant adults with type 2 diabetes mellitus: a guidance statement update from the American College of Physicians. Ann Intern Med 2018;168:569–576 - PubMed